Paper17599423
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
Gerstein HC and 10 others. Am J Cardiol, 2007. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Papers, record 17599423. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17599423
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Angiopathies | Major topic |
| Blood Glucose | |
| Coronary Artery Disease | |
| Glycated Hemoglobin | |
| Humans | |
| Hypoglycemic Agents | |
| Randomized Controlled Trials as Topic |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01-HC-95178 | NHLBI NIH HHS | United States | N01HC095178 | PubMed and NIH | NIH RePORTER |
| N01-HC-95179 | NHLBI NIH HHS | United States | N01HC095179 | PubMed and NIH | NIH RePORTER |
| N01-HC-95180 | NHLBI NIH HHS | United States | N01HC095180 | PubMed and NIH | NIH RePORTER |
| N01-HC-95181 | NHLBI NIH HHS | United States | N01HC095181 | PubMed and NIH | NIH RePORTER |
| N01-HC-95182 | NHLBI NIH HHS | United States | N01HC095182 | PubMed and NIH | NIH RePORTER |
| N01-HC-95183 | NHLBI NIH HHS | United States | N01HC095183 | PubMed and NIH | NIH RePORTER |
| N01-HC-95184 | NHLBI NIH HHS | United States | N01HC095184 | PubMed and NIH | NIH RePORTER |
| Y1-HC-1010 | NHLBI NIH HHS | United States | PubMed | PubMed | |
| Y1-HC-9035 | NHLBI NIH HHS | United States | PubMed | PubMed |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | Background |
Source ClinicalTrials.gov
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41601869 | Predictors of suboptimal glycemic control in people with type 2 diabetes and overweight or obesity: insights from baseline analysis of a diabetes-specific meal replacement study. | Front Nutr | 2025 | https://conductscience.org/library/papers/41601869 | PubMed |
| 41402851 | Association of metabolic score for visceral fat with cardiovascular risk and total mortality in patients with type 2 diabetes: insights from ACCORD study. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/41402851 | PubMed |
| 40674363 | Association between estimated glucose disposal rate and major adverse cardiovascular events in patients with type 2 diabetes. | PLoS One | 2025 | https://conductscience.org/library/papers/40674363 | PubMed |
| 40577645 | A Responsible Framework for Assessing, Selecting, and Explaining Machine Learning Models in Cardiovascular Disease Outcomes Among People With Type 2 Diabetes: Methodology and Validation Study. | JMIR Med Inform | 2025 | https://conductscience.org/library/papers/40577645 | PubMed |
| 40365617 | Reassessing the Link: Depression and Diabetic Nephropathy in Type 2 Diabetes Mellitus Patients: Insights From the ACCORD-HRQL Study. | Depress Anxiety | 2025 | https://conductscience.org/library/papers/40365617 | PubMed |
| 40226732 | Depressive Symptoms and Metabolic Dysregulation Control: A Closer Look at Control Challenges in T2DM Patients. | Depress Anxiety | 2024 | https://conductscience.org/library/papers/40226732 | PubMed |
| 40102933 | Association between the haemoglobin glycation index and 30-day and 365-day mortality in patients with heart failure admitted to the intensive care unit. | Diabetol Metab Syndr | 2025 | https://conductscience.org/library/papers/40102933 | PubMed |
| 38934867 | Heterogeneous Effects of Intensive Glycemic and Blood Pressure on Cardiovascular Events Among Diabetes by Living Arrangements. | J Am Heart Assoc | 2024 | https://conductscience.org/library/papers/38934867 | PubMed |
| 38419951 | Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38419951 | PubMed |
| 37891565 | Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study. | Cardiovasc Diabetol | 2023 | https://conductscience.org/library/papers/37891565 | PubMed |
| 37828071 | Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65. | Sci Rep | 2023 | https://conductscience.org/library/papers/37828071 | PubMed |
| 37037931 | Protective effect of intensive glucose lowering therapy on all-cause mortality, adjusted for treatment switching using G-estimation method, the ACCORD trial. | Sci Rep | 2023 | https://conductscience.org/library/papers/37037931 | PubMed |
| 36353230 | Obesity is associated with greater cognitive function in patients with type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36353230 | PubMed |
| 36034445 | Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36034445 | PubMed |
| 35669761 | Living Alone Is Not Associated With Cardiovascular Events and Hypoglycemia in Patients With Type 2 Diabetes Mellitus. | Front Public Health | 2022 | https://conductscience.org/library/papers/35669761 | PubMed |
| 35152780 | Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms. | Antioxid Redox Signal | 2022 | https://conductscience.org/library/papers/35152780 | PubMed |
| 35106709 | Changes in fat mass and lean body mass and outcomes in type 2 diabetes mellitus. | Intern Emerg Med | 2022 | https://conductscience.org/library/papers/35106709 | PubMed |
| 34901237 | Association Between Long-Term Visit-to-Visit Hemoglobin A1c and Cardiovascular Risk in Type 2 Diabetes: The ACCORD Trial. | Front Cardiovasc Med | 2021 | https://conductscience.org/library/papers/34901237 | PubMed |
| 34764938 | Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/34764938 | PubMed |
| 34610830 | Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. | Cardiovasc Diabetol | 2021 | https://conductscience.org/library/papers/34610830 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17599423
GET https://conductscience.org/api/papers/v1/17599423/cited_by?page=2